This suggests post-translational inactivation, as in vitro studies in 11 RCC cell lines demonstrated basal DAPK-1 activity in only one cell line despite the detection of DAPK-1 mRNA expression (Wethkamp et al, 2006). This evidence concerns the gene DAPK1 and renal cell carcinoma.